GW&K Investment Management LLC Has $25.69 Million Position in Novanta Inc. $NOVT

GW&K Investment Management LLC reduced its holdings in Novanta Inc. (NASDAQ:NOVT) by 15.9% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 256,541 shares of the technology company’s stock after selling 48,675 shares during the quarter. GW&K Investment Management LLC’s holdings in Novanta were worth $25,693,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Pilgrim Partners Asia Pte Ltd acquired a new stake in Novanta in the third quarter valued at $36,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of Novanta during the third quarter worth about $40,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in shares of Novanta in the 2nd quarter worth approximately $52,000. Huntington National Bank boosted its position in shares of Novanta by 65.7% during the 2nd quarter. Huntington National Bank now owns 492 shares of the technology company’s stock valued at $63,000 after purchasing an additional 195 shares in the last quarter. Finally, Harbor Investment Advisory LLC increased its stake in shares of Novanta by 47.1% in the 3rd quarter. Harbor Investment Advisory LLC now owns 987 shares of the technology company’s stock valued at $99,000 after acquiring an additional 316 shares in the last quarter. Institutional investors own 98.35% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Weiss Ratings raised Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 20th. Robert W. Baird set a $150.00 price objective on shares of Novanta in a research report on Wednesday, February 25th. Finally, Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Novanta presently has an average rating of “Hold” and an average target price of $150.00.

Novanta Price Performance

NOVT opened at $136.59 on Friday. The stock has a market capitalization of $4.87 billion, a P/E ratio of 93.55 and a beta of 1.61. Novanta Inc. has a 12-month low of $98.27 and a 12-month high of $149.95. The stock has a 50-day moving average price of $134.71 and a 200-day moving average price of $120.92. The company has a current ratio of 3.69, a quick ratio of 2.80 and a debt-to-equity ratio of 0.16.

Novanta (NASDAQ:NOVT) last issued its earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The firm had revenue of $258.35 million for the quarter, compared to analysts’ expectations of $260.72 million. During the same quarter last year, the business earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Equities analysts predict that Novanta Inc. will post 3.03 earnings per share for the current fiscal year.

Insider Activity at Novanta

In related news, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $140.88, for a total value of $200,472.24. Following the completion of the transaction, the chief financial officer owned 93,814 shares of the company’s stock, valued at approximately $13,216,516.32. This represents a 1.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the transaction, the chief executive officer owned 57,367 shares of the company’s stock, valued at $8,320,509.68. The trade was a 11.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 24,346 shares of company stock worth $3,382,737 in the last ninety days. Insiders own 1.20% of the company’s stock.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.